Related Experiment Video

Updated: Mar 16, 2026

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
10:20

Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

Published on: June 16, 2008

11.8K

Excision of HIV-1 DNA by gene editing: a proof-of-concept in vivo study

R Kaminski, R Bella, C Yin

    Gene Therapy
    |August 5, 2016
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation
    09:29

    Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

    Published on: February 28, 2025

    3.8K
    Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
    09:51

    Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

    Published on: May 25, 2018

    36.2K

    Related Experiment Videos

    Last Updated: Mar 16, 2026

    Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase
    10:20

    Interview: HIV-1 Proviral DNA Excision Using an Evolved Recombinase

    Published on: June 16, 2008

    11.8K
    Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation
    09:29

    Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

    Published on: February 28, 2025

    3.8K
    Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
    09:51

    Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

    Published on: May 25, 2018

    36.2K

    Related Concept Videos

    CRISPR/Cas9 Genome Editing01:28

    CRISPR/Cas9 Genome Editing

    2.4K
    The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
    2.4K
    CRISPR01:59

    CRISPR

    58.7K
    Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
    58.7K
    In-vitro Mutagenesis01:16

    In-vitro Mutagenesis

    17.6K
    To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
    17.6K

    Articles linked to this work by shared authors, journal, and citation graph.

    [Comparison of the anesthetic effect of different doses of ciprofol combined with oxycodone during the peri-endoscopic period of painless gastroscopy in elderly patients].

    Zhonghua yi xue za zhi·2026

    The biocontrol potential of Streptomyces polychromogenes YKL-11 against apple replant disease: Inhibition of the growth of pathogenic Fusarium and remodelling of soil microbial flora.

    Plant biology (Stuttgart, Germany)·2026

    [Risk factors for adverse prognosis in acute aortic syndrome: a single-center retrospective cohort study].

    Zhonghua xin xue guan bing za zhi·2025

    Next-generation precision medicine for suicidality prevention.

    Translational psychiatry·2024

    Association between gestational cardiovascular health in the first trimester and pregnancy outcomes in the China birth cohort.

    Public health·2024

    Study of association between corneal shape parameters and axial length elongation during orthokeratology using image-pro plus software.

    BMC ophthalmology·2024

    An engineered helper plasmid generates differential E4orf6 and L4-22/33K gene expression increasing AAV vector production.

    Gene therapy·2026

    A gene therapy approach to prevent dilated intercellular space, a hallmark of gastroesophageal reflux disease.

    Gene therapy·2026

    Precision correction of the GJB2 c.235delC mutation by prime editing in vitro.

    Gene therapy·2026

    Bone- and muscle-targeted adeno-associated viral vectors enable tissue-selective vitamin D receptor knockdown in mice.

    Gene therapy·2026

    SACF and GILA for in vitro transformation assessment of CRISPR/Cas9-edited cell therapy candidates: a multi-site study.

    Gene therapy·2026

    rAAV production cost analysis: Indication-specific cost per dose and reduction strategies.

    Gene therapy·2026

    Prediction of blood-brain barrier permeability using modified poly(dimethylsiloxane).

    Analytical methods : advancing methods and applications·2026

    Structural and biophysical characterization of Mycobacterium tuberculosis DciA reveals functional convergence in DnaB helicase recognition.

    Protein science : a publication of the Protein Society·2026

    Individual Patient Data Meta-Analysis of GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface for Treatment of Femoro-Popliteal Arterial Disease (INSIGHT VSX).

    Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2026

    Early balloon-assisted-maturation does not reduce patency of mature arteriovenous fistulae.

    Renal failure·2026

    Real-time monitoring of moist wound healing by a flexible adaptive impedance sensing patch.

    Lab on a chip·2026

    Delayed Arteriovenous Fistula Maturation Associated With an Ipsilateral Transvenous Implantable Cardioverter Defibrillator (ICD) Lead and Suspected Functional Hemodynamic Obstruction.

    Cureus·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us